Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04694417
Other study ID # TampereUH99
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date December 31, 2021

Study information

Verified date January 2021
Source Tampere University Hospital
Contact Tuomas Koskela, Docent
Phone +358407390383
Email tuomas.koskela@tuni.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Leg cramps are painful sensations of tightening in the muscles of the legs, that are often associated with secondary insomnia. They are common especially at an older age. There is no evidence that any method of prevention of nocturnal leg cramps would be both safe and effective. There are no previous trials concerning cramp prevention by using compression stockings. The objective of this study is to assess in a prospective randomised controlled trial whether leg cramps can be prevented by daily use of knee-length compression stockings or magnesium supplements.


Description:

Leg cramps are painful sensations of tightening in the muscles of the legs that commonly appear during the night and are often associated with secondary insomnia. They are common especially in older age. There is no evidence that any method of prevention of nocturnal leg cramps is both safe and effective. There are no previous trials concerning cramp prevention by using compression stockings. The objective of this study is to assess in a prospective randomised controlled trial whether leg cramps can be prevented by the daily use of knee-length compression stockings or magnesium supplements. Methods The study will be set in Finland, and 50-84-year-old volunteers will be recruited through Google Ads, the Finnish Health Library and Finnish primary health care centres. The participants must have a minimum of two episodes of leg cramps per week for the past four weeks to be included in the study. The participants (n = 225) will be allocated to three equal groups: the compression stocking arm, the magnesium supplement arm and the placebo arm. The participants will go through four weeks of follow-up without intervention, and then another four weeks of follow-up with the assigned intervention. The material for the study will be collected through electronic questionnaires. Discussion This protocol describes a study that compares compression stockings, magnesium supplements and placebo for the prevention of leg cramps. The results of this study can significantly improve knowledge on the methods of preventing leg cramps.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 225
Est. completion date December 31, 2021
Est. primary completion date July 31, 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years to 84 Years
Eligibility Inclusion Criteria: - Minimum of two leg cramps per week in the past four weeks. - Age from 50 to 84 years. Exclusion Criteria: - Peripheral artery disease (confirmed or suspected). - Peripheral artery bypass surgery. - Grave peripheral neuropathy or any sensory disorder. - Allergy to the material of the compression stockings. - Grave renal failure (GFR under 30 ml/min). - The use of a magnesium carbonate product (e.g. Rennie® or Berocca®). - Cardiac failure with pulmonary oedema or massive lower limb swelling. - Lower limb soft tissue problems, including skin transplant, thinned skin, varicose ulcer, necrosis and any infection. - Lower limb deformity or atypical shape or size that could prevent the usage of compression stockings. - Continuous usage of compression stockings for any other reason than leg cramps.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Compression stocking
Please see the description of the intervention in another section
Dietary Supplement:
Magnesium tablet
Please see the description of the intervention in another section
Other:
Placebo tablet
Please see the description of the intervention in another section

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Tampere University Hospital Tampere University

Outcome

Type Measure Description Time frame Safety issue
Primary The change in quantity of leg cramps The change in quantity of leg cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The number of cramps will be recoded on a weekly online survey during four weeks before intervention and during the four-week intervention period. The change in the number of cramps from the four-week period prior the intervention to the intervention period will be calculated. The difference between groups will be analyzed by one-way analysis of variance of repeated measurements. 8 weeks
Secondary The change in intensity of leg cramps The possible change in the intensity of leg cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The intensity of cramps will be recoded on a weekly online survey during the four weeks before intervention and during the four-week intervention period. The possible change in the intensity of cramps from the four-week period prior the intervention to the intervention period will be assessed. 8 weeks
Secondary The change in quantity of nocturnal awakening due to the cramps The change in the quantity of nocturnal awakenings due to the cramps from the four-week follow-up period (prior to the intervention) to the four-week intervention period will be assessed on the basis of the participants' responses to the survey. The number of cramps will be recoded on a weekly online survey during four weeks before intervention and during the four-week intervention period. The change in the number of nocturnal awakenings due to the cramps from the four-week period prior the intervention to the intervention period will be calculated. The difference between groups will be analyzed by one-way analysis of variance of repeated measurements. 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04998305 - TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps Phase 1/Phase 2
Completed NCT03176966 - Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis Phase 4
Completed NCT04575090 - 7 Tesla MRI Study in Patients With Statin Related Muscle Complaints N/A
Completed NCT01271660 - A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis Phase 3
Terminated NCT00516516 - Oral Carnitine for Cramps in Pregnancy N/A
Completed NCT04650295 - Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial N/A
Recruiting NCT03660969 - Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease
Completed NCT03802565 - Tolperisone in Acute Muscle Spasm of the Back Phase 2
Completed NCT04901832 - Intradialytic Stretching Exercises on Prevention and Reduction of Leg Muscle Cramps N/A
Completed NCT05457322 - The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps N/A
Terminated NCT04507373 - 7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events Phase 4
Completed NCT00963638 - Beneficial Effects of Magnesium Supplementation On Idiopathic Muscle Cramps N/A
Completed NCT05724485 - Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis Phase 4